Tag: Oncology Drugs
Cipla USA Launches Pomalidomide Capsules, Generic Version of Pomalyst®, in All Strengths
Cipla Limited and its wholly owned subsidiary, Cipla USA Inc., announced the commercial launch of Pomalidomide Capsules in the United States. The generic equivalent of Bristol Myers Squibb's Pomalyst® is...
FDA Reaches Out to Indian Pharma Amid Critical Ifosfamide Shortage in U.S.
A chemotherapy drug that stands between cancer patients and their treatment has gone dangerously scarce in the United States, compelling federal health regulators to...
Alembic wins USFDA approval for Generic Binimetinib
Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application...
Emergency Price Adjustment Approved for Critical Cancer Drugs Amid Raw Material Crisis
In a decisive move to counter critical domestic medicine shortages caused by global macroeconomic headwinds, the Department of Pharmaceuticals (DoP) has granted an in-principle...
